Akero Therapeutics Inc [NASDAQ: AKRO] loss -2.15% on the last trading session, reaching $27.37 price per share at the time. The company report on March 8, 2024 at 4:02 PM that Akero Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of
Akero Therapeutics Inc [NASDAQ: AKRO] traded at a high on Monday, posting a 11.72 gain after which it closed the day’ session at $31.07. The company report on March 4, 2024 at 4:21 PM that Akero Therapeutics Announces Proposed Public Offering of Common Stock. J.P.
Akero Therapeutics Inc [NASDAQ: AKRO] closed the trading session at $17.76. The company report on January 3, 2024 at 8:15 AM that Akero Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference. A live webcast of the Company presentation will be available through
In pre-market trading, shares of Akero Therapeutics Inc. (Nasdaq: AKRO) were up 77.67% to $21.80 after encouraging clinical trial data were announced. In Monday’s session, AKRO stock gained 4.78% to close at $12.27 with 0.68 million shares changing hands. AKRO has shared what? Today, Akero
© 2024, Powered by Smart TechOne
